Goldman Sachs Alternatives takes control of Italian medtech platform Numantec

Goldman Sachs Alternatives has agreed to acquire a controlling stake in Italian medical technology manufacturer Numantec from private equity firm White Bridge Investment, marking another investment in the healthcare sector, according to a report by Reuters.

Original Source

Read the full article at Privateequitywire →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.